227 related articles for article (PubMed ID: 19733106)
1. Effects of low-dose intranasal (S)-ketamine in patients with neuropathic pain.
Huge V; Lauchart M; Magerl W; Schelling G; Beyer A; Thieme D; Azad SC
Eur J Pain; 2010 Apr; 14(4):387-94. PubMed ID: 19733106
[TBL] [Abstract][Full Text] [Related]
2. S(+)-ketamine effect on experimental pain and cardiac output: a population pharmacokinetic-pharmacodynamic modeling study in healthy volunteers.
Sigtermans M; Dahan A; Mooren R; Bauer M; Kest B; Sarton E; Olofsen E
Anesthesiology; 2009 Oct; 111(4):892-903. PubMed ID: 19741495
[TBL] [Abstract][Full Text] [Related]
3. Exploring the pharmacokinetics of oral ketamine in children undergoing burns procedures.
Brunette KE; Anderson BJ; Thomas J; Wiesner L; Herd DW; Schulein S
Paediatr Anaesth; 2011 Jun; 21(6):653-62. PubMed ID: 21355949
[TBL] [Abstract][Full Text] [Related]
4. Effects of norketamine enantiomers in rodent models of persistent pain.
Holtman JR; Crooks PA; Johnson-Hardy JK; Hojomat M; Kleven M; Wala EP
Pharmacol Biochem Behav; 2008 Oct; 90(4):676-85. PubMed ID: 18586315
[TBL] [Abstract][Full Text] [Related]
5. Interaction between morphine and norketamine enantiomers in rodent models of nociception.
Holtman JR; Crooks PA; Johnson-Hardy J; Wala EP
Pharmacol Biochem Behav; 2008 Oct; 90(4):769-77. PubMed ID: 18582492
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamic profiles of ketamine (R)- and (S)- with 5-day inpatient infusion for the treatment of complex regional pain syndrome.
Goldberg ME; Torjman MC; Schwartzman RJ; Mager DE; Wainer IW
Pain Physician; 2010; 13(4):379-87. PubMed ID: 20648207
[TBL] [Abstract][Full Text] [Related]
7. S-ketamine and s-norketamine plasma concentrations after nasal and i.v. administration in anesthetized children.
Weber F; Wulf H; Gruber M; Biallas R
Paediatr Anaesth; 2004 Dec; 14(12):983-8. PubMed ID: 15601346
[TBL] [Abstract][Full Text] [Related]
8. Ketamine and norketamine plasma concentrations after i.v., nasal and rectal administration in children.
Malinovsky JM; Servin F; Cozian A; Lepage JY; Pinaud M
Br J Anaesth; 1996 Aug; 77(2):203-7. PubMed ID: 8881626
[TBL] [Abstract][Full Text] [Related]
9. A pilot open-label study of the efficacy of subanesthetic isomeric S(+)-ketamine in refractory CRPS patients.
Kiefer RT; Rohr P; Ploppa A; Nohé B; Dieterich HJ; Grothusen J; Altemeyer KH; Unertl K; Schwartzman RJ
Pain Med; 2008; 9(1):44-54. PubMed ID: 18254766
[TBL] [Abstract][Full Text] [Related]
10. Modeling the norketamine metabolite in children and the implications for analgesia.
Herd DW; Anderson BJ; Holford NH
Paediatr Anaesth; 2007 Sep; 17(9):831-40. PubMed ID: 17683400
[TBL] [Abstract][Full Text] [Related]
11. Stereoselective pharmacokinetics of ketamine and norketamine after racemic ketamine or S-ketamine administration during isoflurane anaesthesia in Shetland ponies.
Larenza MP; Landoni MF; Levionnois OL; Knobloch M; Kronen PW; Theurillat R; Schatzmann U; Thormann W
Br J Anaesth; 2007 Feb; 98(2):204-12. PubMed ID: 17218377
[TBL] [Abstract][Full Text] [Related]
12. Antinociceptive effects, metabolism and disposition of ketamine in ponies under target-controlled drug infusion.
Knobloch M; Portier CJ; Levionnois OL; Theurillat R; Thormann W; Spadavecchia C; Mevissen M
Toxicol Appl Pharmacol; 2006 Nov; 216(3):373-86. PubMed ID: 16919695
[TBL] [Abstract][Full Text] [Related]
13. Ketamine for pain: an update of uses in palliative care.
Prommer EE
J Palliat Med; 2012 Apr; 15(4):474-83. PubMed ID: 22500483
[TBL] [Abstract][Full Text] [Related]
14. NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride.
Felsby S; Nielsen J; Arendt-Nielsen L; Jensen TS
Pain; 1996 Feb; 64(2):283-291. PubMed ID: 8740606
[TBL] [Abstract][Full Text] [Related]
15. Plasma concentration profiles of ketamine and norketamine after administration of various ketamine preparations to healthy Japanese volunteers.
Yanagihara Y; Ohtani M; Kariya S; Uchino K; Hiraishi T; Ashizawa N; Aoyama T; Yamamura Y; Yamada Y; Iga T
Biopharm Drug Dispos; 2003 Jan; 24(1):37-43. PubMed ID: 12516077
[TBL] [Abstract][Full Text] [Related]
16. Stereoselective pharmacokinetics of ketamine and norketamine after racemic ketamine or S-ketamine administration in Shetland ponies sedated with xylazine.
Larenza MP; Knobloch M; Landoni MF; Levionnois OL; Kronen PW; Theurillat R; Schatzmann U; Thormann W
Vet J; 2008 Sep; 177(3):432-5. PubMed ID: 17604192
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of ketamine and its major metabolites norketamine, hydroxynorketamine, and dehydronorketamine: a model-based analysis.
Kamp J; Jonkman K; van Velzen M; Aarts L; Niesters M; Dahan A; Olofsen E
Br J Anaesth; 2020 Nov; 125(5):750-761. PubMed ID: 32838982
[TBL] [Abstract][Full Text] [Related]
18. Disposition of ketamine and norketamine in hair after a single dose.
Xiang P; Sun Q; Shen B; Shen M
Int J Legal Med; 2011 Nov; 125(6):831-40. PubMed ID: 21153031
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of ketamine and its metabolite norketamine administered at a sub-anesthetic dose together with xylazine to calves prior to castration.
Gehring R; Coetzee JF; Tarus-Sang J; Apley MD
J Vet Pharmacol Ther; 2009 Apr; 32(2):124-8. PubMed ID: 19290941
[TBL] [Abstract][Full Text] [Related]
20. Sub-dissociative-dose intranasal ketamine for moderate to severe pain in adult emergency department patients.
Yeaman F; Meek R; Egerton-Warburton D; Rosengarten P; Graudins A
Emerg Med Australas; 2014 Jun; 26(3):237-42. PubMed ID: 24712757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
